The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

More reading

• Three ASX shares to buy right now according to Morgans
• Leading brokers name 3 ASX shares to buy today
• Here’s why the ASX 200 is falling despite a sea of green
• Why 4DMedical, Eagers Automotive, IDP Education, and oOh!Media shares are charging higher today
• Why this ASX 200 stock is climbing after a $2 million insider buy

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia has recommended Eagers Automotive Ltd, Gqg Partners, Premier Investments, and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It seems that the initial public offering (IPO) of SpaceX (NASDAQ: SPCX) shares is quickly turning into one of the biggest spectacles the investing world has ever seen. I don’t know about you, but I can’t recall a time when the floating of an American company on the American stock markets prompted Australian brokers like CommSec to offer Australian investors the chance to participate.

And participate they seemingly are. Every time I have logged onto CommSec’s website in recent weeks, I have been greeted with “We’re experiencing extremely high call volumes”, followed by a prompt explaining to visitors how they can participate in the IPO. 

To labour the point one more time, this is unprecedented.

SpaceX shares’ IPO to shake up the world of investing

It seems more than a few Australian investors are relishing the opportunity to buy SpaceX shares as soon as they can.

SpaceX, helmed by Elon Musk, is behind some of the world’s most advanced rocket technology. The company has several supplementary divisions, including its Starlink satellite internet services, artificial intelligence platform xAI, and the social media site X, formerly known as Twitter.

Musk already heads up electric battery and vehicle company Tesla Inc (NASDAQ: TSLA). SpaceX will be his second public company, and, if the IPO goes off as planned, the second of Musk’s companies to find a spot in the top ten largest stocks listed on the US markets.

Given this fact, it’s not hard to see why some are speculating that this IPO could well make Elon Musk the world’s first trillionaire.

However, Musk is a divisive figure for a multitude of reasons. Not all Australians would relish the chance to own shares of one of his companies. Unfortunately for those investors, we may not have a choice.

As we’ve already touched on, SpaceX looks destined to become one of the largest public companies in the world when it IPOs. The company is aiming for a market capitalisation of US$2.5 trillion. If hit, that would put it as the USA’s sixth-largest public company, right between Amazon.com Inc (NASDAQ: AMZN) and Broadcom Inc (NASDAQ: AVGO).

This fact makes it almost impossible for Australians to avoid having money tied up in SpaceX shares. Let me explain why.

Index funds and super

Firstly, anyone who owns a US-centric ASX exchange-traded fund (ETF) or index fund will own SpaceX shares. Popular ASX ETFs, whether it be the Vanguard MSCI Index International Shares ETF (ASX: VGS), the iShares S&P 500 ETF (ASX: IVV), or the BetaShares Nasdaq 100 ETF (ASX: NDQ), will all have to hold SpaceX as a relatively major holding. So if you own any of these funds, or the myriad of ETFs that offer exposure to the US markets, a slice of SpaceX stock will indirectly arrive in your brokerage account soon after the IPO fires off.

But even Australians who don’t own an international index fund or ETF will likely be exposed to SpaceX shares.

That’s because the vast majority of our superannuation funds allocate a large chunk of your money for investment in international shares. The US markets typically occupy a large chunk of that allocation, and typically include the market’s largest companies. Of which SpaceX looks likely to join the ranks.

As such, for better or worse, it seems none of us will be able to avoid an investment in SpaceX when the company goes public. Hopefully it works in our favour.

The post Don’t want to buy SpaceX shares? You may not have a choice appeared first on The Motley Fool Australia.

More reading

• 3 ASX small-cap shares to buy: Morgans
• Up 90% in a month, why did Megaport shares just get downgraded?
• Three ASX shares to buy right now according to Morgans
• Down 28% in a year, should I buy the dip on Resmed shares right now?
• Leading brokers name 3 ASX shares to buy today

Motley Fool contributor Sebastian Bowen has positions in Amazon. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon, BetaShares Nasdaq 100 ETF, Broadcom, Tesla, and iShares S&P 500 ETF. The Motley Fool Australia has positions in and has recommended BetaShares Nasdaq 100 ETF. The Motley Fool Australia has recommended Amazon, Vanguard Msci Index International Shares ETF, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX small-cap shares are underperforming the broader market in 2026.

An ASX small-cap share typically has a market capitalisation of between approximately $300 million and $2 billion.

The S&P/ASX Small Ords Index (ASX: XSO) is down 9.8% versus a 2.3% dip in the S&P/ASX All Ords Index (ASX: XAO) year-to-date.

However, Morgans sees opportunity with these three ASX small-cap shares.

Let’s find out why.

Tasmea Ltd (ASX: TEA)

The Tasmea share price is $8.14, down 1.1% today and up 94% in the calendar year to date (YTD).

Tasmea is a skilled services company that provides essential maintenance, engineering, and specialised project services.

The company operates in many industries including mining, oil and gas, waste and water, power and renewable energy, and defence.

Morgans has a buy rating on this ASX small-cap share in the industrials sector.

In a new note, the broker raised its 12-month share price target substantially from $5.25 to $9.15 following acquisition news.

Morgans said:

TEA has agreed to acquire Victorian specialist electrical contractor Maxim Group for up to $254m (~5.4x FY26F EV/EBIT).

The deal is ~31% EPS accretive, scales TEA’s Electrical segment to >$100m EBIT and diversifies earnings away from resources into data centres, infrastructure and Battery Energy Storage Systems (BESS).

TEA will look to leverage its regional expertise as data centres increasingly move out of metropolitan areas.

Maxim’s owner-led team is retained and aligned via scrip and a three-year earn-out.

We make meaningful EPS changes of +30-34% in each of FY27 and FY28. BUY maintained.

Vysarn Ltd (ASX: VYS)

The Vysarn share price is 94 cents, up 2.4% today and up 28% YTD.

Vysarn provides production-critical services to the resources, construction, and utilities industries. 

Morgans upgraded this ASX materials small-cap share after Vysarn announced it was buying an irrigations systems company.

The broker lifted its rating from speculative buy to buy, and raised its target price from 90 cents to $1.10.

The broker said:

VYS is acquiring NewGround, adding highly accretive (~25% EPS) annuity-style earnings that, alongside greater customer-base diversification in the industrial division, materially increases earnings visibility.

The limited upfront cash component of $8.3m preserves balance sheet flexibility, providing further capacity to continue building out its integrated water-services platform via acquisitions.

Incorporating NewGround from early October, we raise our EPS forecasts in FY27 and FY28 by +19 and +24% respectively.

Reflecting the improvement in earnings quality and reduced volatility, we upgrade VYS from Speculative Buy to Buy.

While the Kariyarra asset management business carries a binary outcome, at the current share price, investors are getting this optionality for free.

Tourism Holdings Ltd (ASX: THL)

The Tourism Holdings share price is $2.06, up 1.5% today and down 10% YTD.

Tourism Holdings rents and sells holiday campervans in Australia, New Zealand, and the US.

Morgans has a buy rating on this ASX industrials small-cap share with a $2.58 target.

In a new note, the broker said:

Unsurprisingly, given the conflict in the Middle East, THL has revised its FY26 NPAT guidance given weaker than expected RV sales.

The conflict, higher fuel prices and cost of living pressures push out the earnings recovery despite all of THL’s internal initiatives to improve the business.

Tourism Holdings is also listed on the New Zealand Stock Exchange at NZ$2.47 per share.

Morgans notes that BGH Capital and the Trouchet shareholders have issued a revised takeover offer of NZ$3.10 for the company.

The post 3 ASX small-cap shares to buy: Morgans appeared first on The Motley Fool Australia.

More reading

• This special dividend could deliver a windfall gain, and it’s not too late to buy in
• Tasmea share price rockets as it enters data centre race
• Which ASX travel company is up more than 30% on takeover talks?
• Could this surging ASX small cap still be hiding in plain sight?
• Are these ASX shares a buy, hold or sell after rocketing to record highs last week?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Vysarn. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Megaport Ltd (ASX: MP1) shares rocketed 19% higher last week, and set a new 52-week high of $21.16 on Friday.

The share price spike followed Megaport’s announcement that it had won four new AI infrastructure contracts worth $458.9 million.

The contracts necessitate major capital expenditure, so Megaport launched a fully underwritten $827.3 million entitlement offer.

The company completed the institutional component of the offer, priced at $14.30 per share, on Friday.

Today, Megaport shares are maintaining their upward trajectory despite the broader market sinking into the red.

Megaport shares are 0.65% higher at $18.60 while the S&P/ASX 200 Index (ASX: XJO) is down 0.2%.

Broker downgrades winning ASX 200 tech share

Morgans has just published a new note on Megaport shares.

The broker downgraded the ASX 200 tech share from a buy to accumulate rating.

Morgans points out that it did so following a 90% increase in the Megaport share price over just one month.

The broker also lifted its 12-month target price from $15.50 to $21.

Morgans said:

MP1’s move to expand TAM from comms to compute has paid off handsomely over the last few months with more compute ARR sold in the last 1.5 months than comms ARR has been sold in the last 13 years.

This success in compute is symbiotic with the core communications platform and AI where GPU’s further deepen this symbiotic relationship. Consequently, MP1 is launching an on-demand globally distributed AI Inference cloud.

This, plus recent take-or-pay-style contract wins has prompted a ~A$809m capital raise.

We materially lift our earnings and our Target Price lifts to $21 per share.

It was less than a month ago that Morgans reaffirmed its buy rating on Megaport shares and raised its target from $13.50 to $15.50.

An accumulate rating means Morgans is still optimistic on this ASX 200 tech share, and still recommends buying it.

However, the accumulate rating signals a bit of caution, given the 12-month price target implies only 13% upside from here.

Entitlement offer for retail investors opens Thursday

The institutional component of the entitlement offer raised about $518 million.

Management expects the retail component, to be offered to ordinary investors from Thursday, will raise $309 million.

Investors who already held Megaport shares at 7pm last Friday are entitled to participate in the offer.

The retail component will close at 5pm (Sydney time) on Monday, 29 June.

Under the offer, shareholders are entitled to apply for one new Megaport share for every 3.08 shares they already own.

Details about how to apply for the new Megaport shares will be in the retail offer booklet, available Thursday.

The post Up 90% in a month, why did Megaport shares just get downgraded? appeared first on The Motley Fool Australia.

More reading

• Why are ASX 200 tech stocks like WiseTech, Life360 and Xero shares getting hammered on Tuesday?
• Buy, hold, sell: Megaport, Bendigo Bank, BHP shares
• 7 ASX shares set to soar 30% to 90% in 12 months: experts
• ASX 200 tech stocks led the market with big share price gains last week
• Top brokers name 3 ASX shares to buy next week

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Megaport. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The team at Morgans has issued new research reports this week, setting out the case for buying shares in three very different sectors.

They reckon there’s upside of a minimum 28.4% to be had among the trio, with one share, admittedly a speculative buy, tipped to more than double.

Let’s have a look at the companies they like.

Civmec Ltd (ASX: CVL)

Shares in Civmec recently hit record highs and have delivered a return of more than 70% over the past year.

That’s perhaps not a surprise, given the company’s announcement last week that its order book had hit a record high of $1.5 billion.

This followed the company being awarded a further package of work by Iluka Resources Ltd (ASX: ILU) at its Eneabba Rare Earths Refinery in Western Australia.

Civmec was also awarded the major construction contract for Perth Park, “Western Australia’s premier entertainment and sporting precinct on the Burswood Peninsula”.

The company also said:

Civmec has recently secured a number of new awards, panel agreement extensions and new orders across its maintenance portfolio, increasing utilisation at its permanent regional facilities. The Group has also secured packages of work from long-term clients across the lithium, rare earths, critical minerals, iron ore, coal, alumina and hydrocarbons commodities, as well as manufacturing work to be delivered from its Newcastle facility.

The Morgans analyst team said they believed the Iluka and Perth Park contracts “almost entirely de-risks expectations for strong earnings growth in FY27”.

They added:

We expect Civmec to enjoy a strong 12-24 months given increased earnings certainty and an unprecedented outlook supported by capex programs across a broad range of commodities.

Morgans has a price target of $2.30 on Civmec shares compared to $1.79 currently.

IDP Education Ltd (ASX: IEL)

The Morgans team said on the downside, visa data in IDP’s key markets “remains in deep contraction”, with Australia, Canada, and the UK all experiencing material declines.

But on the upside, China is scaling quickly, they said, “and the group continues to demonstrate pricing power across both IELTS and Student Placement”.

IELTS is the globally recognised standard test for English language proficiency.

Morgans said they viewed IDP’s earnings reset as “cyclical rather than structural”.

They added:

Visa restrictions have tightened across all four key destination markets, compressing volumes materially, but underlying demand for international study remains supported by Asian demographics and IDP retains clear market leadership in both IELTS and student placement. Yield growth through the downturn speaks to genuine franchise pricing power. We see scope for earnings to stabilise and return to growth from FY27, led by the completed A$25m cost-out, China IELTS optionality and a stabilising placement backdrop as policy settings evolve.

Morgans has a price target of $3.15 on IDP shares compared to $2.11 currently.

Comet Ridge Ltd (ASX: COI)

This company recently renegotiated a deal with Santos Ltd (ASX: STO) under which it would acquire the larger company’s interest in the Mahalo gas project.

The renegotiation required a smaller up-front cash payment, and also extended the completion date by three months.

The Morgans team said Comet Ridge had successfully used the uncertainty around Federal gas policy to its advantage.

They said the company was trading at a heavily discounted rate with regard to its gas holdings, and they have a price target of 27 cents on the shares compared to 12.5 cents currently, with a speculative buy rating.

The post Three ASX shares to buy right now according to Morgans appeared first on The Motley Fool Australia.

More reading

• Leading brokers name 3 ASX shares to buy today
• Why 4DMedical, Eagers Automotive, IDP Education, and oOh!Media shares are charging higher today
• These shares are being dumped from the ASX 200 index
• This ASX stock just hit a record high. Here’s why investors are buying
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ResMed Inc (ASX: RMD) shares are marching higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) sleep disorder treatment company closed on Friday trading for $27.64. In afternoon trade on Tuesday, following the Monday King’s Birthday ASX trading holiday, shares are swapping hands for $27.91 apiece, up 1%.

For some context, the ASX 200 is down 0.3% at this same time.

Taking a step back, however, ResMed shares remain down 28.2% over the past 12 months, materially lagging the 0.2% one-year gains of the benchmark index.

Which brings us back to our headline question.

Resmed shares: Buy, hold, or sell?

MPC Markets’ Mark Gardner recently analysed the outlook for the ASX healthcare stock (courtesy of The Bull).

“ResMed remains a high-quality respiratory care business,” he noted.

Addressing the past year’s selling pressure, Gardner noted:

Concerns about the impact of GLP-1 weight loss drugs have weighed on sentiment, although recent analysis suggests the big undiagnosed sleep apnoea market still provides a long runway for device demand.

He added:

The company continues to benefit from a strong mask and device portfolio, but investors were disappointed management left its fiscal year 2026 outlook unchanged after a solid third quarter result.

Connecting the dots, Gardner issued a hold recommendation on ResMed shares.

“Our hold recommendation balances the quality of the franchise against near term uncertainty around margins, competition and investor expectations,” he concluded.

What’s the latest from the ASX 200 healthcare share?

ResMed released the third-quarter results Gardner mentioned above on 1 May.

Highlights included revenue of US$1.43 billion. That was up 11% year on year, or up 8% in constant currency.

The quarter also saw ResMed achieve an operating cash flow of US$554 million, with US$262 million returned to shareholders through share repurchases and dividends.

ResMed pays dividends on a quarterly basis.

“Our third quarter results reflect the continued strength of our global business, driven by ongoing demand for our market-leading products and disciplined execution of our strategy,” ResMed CEO Mick Farrell said.

Farrell added:

These results highlight the momentum behind our strategy, and the continued progress we are making in shaping the future of sleep health, breathing health, and healthcare in the home.

As we advance through the remainder of our fiscal year 2026, we remain focused on expanding access to care globally, scaling our digital health capabilities, and delivering further strong, profitable growth.

Amid high expectations and potentially the lack of an FY 2026 outlook upgrade, ResMed shares closed down 7.6% on the day of the results release.

The post Down 28% in a year, should I buy the dip on Resmed shares right now? appeared first on The Motley Fool Australia.

More reading

• How to invest in ASX shares when you don’t know what to buy
• Where to invest $2,000 in ASX 200 shares in June
• Which are the best ASX shares to buy now for FY27?
• 3 ASX 200 healthcare shares to buy while they’re on sale
• Are CSL and ResMed shares buys at 52-week lows?

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are outlined below. Here’s why they are bullish on them:

CSL Ltd (ASX: CSL)

According to a note out of UBS, its analysts have retained their buy rating on this biotech giant’s shares with a reduced price target of $158.00. UBS is feeling upbeat about the company’s outlook, believing that this year could mark the low point for CSL’s profits. This is particularly the case given the cost savings that the company’s transformation program is targeting and lower plasma costs following a shift in collections. In light of this and the CSL share price trading at a discount to peer multiples, UBS thinks now could be an opportune time for investors to buy shares. The CSL share price is trading at $99.19 this afternoon.

Eagers Automotive Ltd (ASX: APE)

A note out of Bell Potter reveals that its analysts have retained their buy rating on this automotive retailer’s shares with a slightly trimmed price target of $28.00. Bell Potter believes the Eagers Automotive shares look reasonable value trading on PE ratios of ~20x and ~17x in 2026 and 2027. The latter includes the first full year of the CanadaOne investment, which it feels is the more relevant PE multiple to focus on. In addition, Bell Potter believes that the recent trading update at the annual general meeting has effectively wiped the slate clean, so there should be no surprises with its half-year results. The Eagers Automotive share price is fetching $21.53 at the time of writing.

IDP Education Ltd (ASX: IEL)

Analysts at Morgans have upgraded this student placement and language testing platform provider’s shares to a buy rating with a $3.15 price target. According to the note, recent visa data shows that IDP Education’s key destination markets remain in deep contraction, with Australia, Canada, and the UK all experiencing material volume and visa grant rate declines. However, positively, the company’s China IELTS is scaling quickly, the cost base reset is on track, and it continues to demonstrate pricing power across both IELTS and Student Placement. So, with structural demand drivers for international study intact, a leaner cost base, growing China optionality, and ongoing technology/product development, Morgans is willing to look through the near-term backdrop and recommends investors buy its shares while they are trading on a cyclically depressed multiple. The IDP Education share price is trading at $2.11 on Tuesday.

The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

More reading

• Has the CSL share price finally bottomed out?
• Why 4DMedical, Eagers Automotive, IDP Education, and oOh!Media shares are charging higher today
• Why this ASX 200 stock is climbing after a $2 million insider buy
• Bell Potter just tipped 12% to 34% upside for these consumer discretionary stocks
• These shares are being dumped from the ASX 200 index

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL and Eagers Automotive Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) has had a volatile start to the year, inflation woes and geopolitical instability putting pressure on investor sentiment and share prices.

The ASX 200 is trading in the red again on Tuesday, down around 0.3% at the time of writing.

Here are two ASX 200 shares I think can drive the ASX 200 Index higher throughout the remainder of 2026. And with upsides as high as 100%, they look super cheap right now.

Life360 Inc (ASX: 360)

Life360 shares are around 1% higher at the time of writing, and changing hands at $22.22 a piece. It’s good news for the US-based software development company’s shares after a run of share price falls.

The ASX 200 tech company’s shares are now around 60% below an all-time high recorded in October last year, and 32% lower for the year to date. 

Life360 shares have been caught up in an ongoing tech-sector-wide sell-off over the past nine months, as investors sold their tech shares amid growing fears that companies’ core services could be replaced by AI. 

At the same time, there has been some concern that some tech company share prices, including Life360, had become overpriced and were trading above fair value.

But I think the oversold ASX 200 shares show great potential for growth.

Life360 recently reported a 38% increase in quarterly revenue, mostly driven by a 32% increase in subscription revenue and a 36% increase in core subscription revenue. The company also upgraded its FY26 adjusted EBITDA and revenue guidance, showing that the business is profitable and performing well.

Market Index data shows that all brokers have a strong buy rating on the stock. The $32.05 average target price implies a potential 44% upside at the time of writing.

Flight Centre Travel Group Ltd (ASX: FLT)

Flight Centre shares are also up around 1% in Tuesday afternoon trade, to $11.11 each.

The ASX 200 travel shares are now down around 26% year to date and are roughly 16% lower than 12 months ago. 

Flight Centre rallied well through late-2025 and early-2026 and peaked at a 52-week high in early February this year.

But a slower-than-expected profit growth, higher travel costs, geopolitical tensions, and inflation concerns pulled the brakes on the share price in February and March. And Flight Centre shares have still struggled to rebound.

As travel disruptions and fuel supply concerns ease, I think ASX 200 travel stocks like Flight Centre could rebound quickly.

Brokers unanimously rate Flight Centre shares as a strong buy and tip a 41% upside to an average $15.61 target price, at the time of writing.

West African Resources Ltd (ASX: WAF)

The Australia-based gold mining company’s shares have fallen over 4% on Tuesday afternoon, and are trading at $2.96 at the time of writing.

The gold miner’s shares have been volatile this year, trading between $2.71 and $3.91 per share. For the year to date, the shares are now down around 4%, but after a huge rally late 2025, the share price is 29% higher than it was 12 months ago.

The ASX 200 gold miner has faced headwinds from higher mining costs and softer gold prices. Investor sentiment dropped, and they began selling their gold shares and rotating into larger, more stable assets instead. 

But West African Resources has posted record-breaking production results this year and recently raised its production guidance for FY26 and the next 10 years. The ASX 200 gold miner forecasts production of 430,000 to 490,000 ounces of gold, which implies production up to 63% higher than FY25.

The gold price is forecast to rebound this year. If gold prices return to record highs, then the value of high-performing gold miners like West African Resources could accelerate.

Brokers unanimously rate the ASX 200 gold miner’s shares as a strong buy, and the average $5.89 target price implies a potential 100% upside at the time of writing. 

The post These 3 oversold ASX 200 shares look cheap right now appeared first on The Motley Fool Australia.

More reading

• Why are ASX 200 tech stocks like WiseTech, Life360 and Xero shares getting hammered on Tuesday?
• Forget SpaceX shares and buy these ASX tech stocks
• Here are the 10 most shorted ASX shares
• ASX 200 tech stocks led the market with big share price gains last week
• 3 ASX 200 shares that could be too good to ignore in June

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended Flight Centre Travel Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) is lower on Tuesday, despite plenty of stocks trading higher.

At the time of writing, the benchmark index is down 0.29% to 8,600 points. It was much weaker earlier, falling as low as 8,490.9 points before recovering some lost ground.

At the latest check, 111 ASX 200 shares were trading higher, compared with 87 lower and 2 unchanged.

Usually, that would be enough to help the index, but the selling is landing in some of the market’s largest stocks.

Here’s the latest.

A few heavyweights are doing the damage

Today, the main pressure is coming from the big miners.

BHP Group Ltd (ASX: BHP) shares are down 2.08% to $59.965 at the time of writing.

Rio Tinto Ltd (ASX: RIO) shares are also weaker, falling 1.62% to $181.59, while Fortescue Ltd (ASX: FMG) shares are down 3.56% to $19.80.

The weakness comes as investors stay cautious on the resources sector.

Iron ore is still sitting near US$101 a tonne after falling over the past month, while demand from China and broader global growth signals remain in focus.

Gold miners are also weighing on the market.

Northern Star Resources Ltd (ASX: NST) shares are down 4.50% to $18.985, even though gold is slightly higher today at around US$4,337 an ounce.

Banks are not offering enough support

The big banks aren’t giving the ASX 200 much help either.

Commonwealth Bank of Australia (ASX: CBA) shares are up 0.11% to $161.07, which is helping limit the damage.

But the other major banks are not following it higher.

Westpac Banking Corp (ASX: WBC) shares are down 0.52% to $34.63, National Australia Bank Ltd (ASX: NAB) shares are down 1.09% to $36.19, and ANZ Group Holdings Ltd (ASX: ANZ) shares are down 0.26% to $34.03.

There are still buyers around

There are still plenty of green screens away from the miners and banks.

Wesfarmers Ltd (ASX: WES) shares are up 1.57% to $80.17 at the time of writing, while Telstra Group Ltd (ASX: TLS) shares are 2.52% higher at $5.09.

Woolworths Group Ltd (ASX: WOW) shares are also stronger, rising 2.19% to $36.47, while CSL Ltd (ASX: CSL) shares are up 1.46% to $99.34.

QBE Insurance Group Ltd (ASX: QBE) is also in the green, with its shares up 1.43% to $22.99.

The number of stocks rising shows investors are still buying selectively. But with the big miners and banks still weighing down the benchmark, the ASX 200 remains stuck in the red.

The post Here’s why the ASX 200 is falling despite a sea of green appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Tuesday
• ASX 200 tech stocks led the market with big share price gains last week
• The average Australian superannuation balance: 50 vs 60 years old
• Why is the ASX 200 falling when so many stocks are rising?
• Atlas Arteria reiterates ‘reject’ on IFM bid, maintains 2026 distribution guidance

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Wesfarmers. The Motley Fool Australia has positions in and has recommended Telstra Group and Woolworths Group. The Motley Fool Australia has recommended BHP Group, CSL, and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

4DMedical Ltd (ASX: 4DX) shares are charging higher today.

Again.

Shares in the S&P/ASX 200 Index (ASX: XJO) respiratory imaging technology company closed on Friday trading for $3.97. In early afternoon trade on Tuesday, with the ASX having been shuttered on Monday for the King’s Holiday, shares are swapping hands for $4.13 apiece, up 4%.

For some context, the ASX 200 is down 0.4% at this same time.

Taking a step back, 4D Medical shares are now up an eye-popping 1,276.7% over the past 12 months, compared to a 1.4% gain delivered by the benchmark index.

And it was thanks to this rapid share price gain, and the resulting market cap surge, that 4DMedical stock was included in the ASX 200 back on 20 April.

To put the past year’s gains into better perspective, if you’d invested $10,000 in the ASX 200 healthcare stock 12 months ago, you’d be sitting on $137,667 today.

And looking ahead, MPC Markets’ Mark Gardner forecasts more outperformance to come (courtesy of The Bull).

Here’s why.

Should I buy 4DMedical shares today?

“4DMedical develops advanced respiratory imaging technology,” Gardner explained.

Commenting on his bullish outlook for the ASX 200 healthcare stock, he said:

The company has attracted attention after securing commercial validation through relationships with GSK, Mayo Clinic and Philips, which support the case for broader adoption of its CT:VQ technology in the United States and other markets.

Sounding a word of caution, Gardner noted, “The shares remain volatile, and the business is still in the early stages of converting partnerships into material revenue.”

Indeed, while 4DMedical shares are up a stellar 1,277% in 12 months, shares are down 9% in 2026. And that comes after they hit an all-time closing high of $6.80 each on 10 April.

But taking a long-term view, Gardner believes the company is still undervalued at current levels.

He concluded:

However, the company has a stronger funding position after its recent capital raise and a clearer commercial pathway than in prior years. We believe the market is undervaluing the longer-term opportunity at recent levels.

What’s the latest from the ASX 200 healthcare stock?

4DMedical shares closed up 18.9% on 29 May after the company announced that it had inked a commercial agreement with US-based SimonMed Imaging for the immediate clinical deployment of its CT:VQ technology.

Commenting on the agreement on the day, 4DMedical CEO and founder Andreas Fouras said:

SimonMed is one of the largest and most influential outpatient imaging providers in the United States. Their decision to adopt CT:VQ, moving directly to commercial deployment, is a major milestone for 4DMedical and a strong validation of both our technology and our clinical value.

The post Up 1,277% in a year, why 4DMedical shares are tipped for more outsized gains appeared first on The Motley Fool Australia.

More reading

• Why 4DMedical, Eagers Automotive, IDP Education, and oOh!Media shares are charging higher today
• Buy, hold, sell: 4DMedical, Cochlear, Westpac shares
• Top brokers name 3 ASX shares to buy next week
• Here are the top 10 ASX 200 shares today
• Buy, hold, sell: Tabcorp, 4DMedical, BHP shares

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended GSK. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.